Lisinopril and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data
Paranasal sinus hypersecretion is found among people who take Lisinopril, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Lisinopril and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 311,375 people who have side effects when taking Lisinopril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
311,375 people reported to have side effects when taking Lisinopril.
Among them, 147 people (0.05%) have Paranasal sinus hypersecretion.
What is Lisinopril?
Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 305,799 Lisinopril users for its effectiveness, alternative drugs and more.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 655 drugs and 375 conditions by eHealthMe.
Number of Lisinopril and Paranasal sinus hypersecretion reports submitted per year:
Gender of people who have Paranasal sinus hypersecretion when taking Lisinopril*:
Age of people who have Paranasal sinus hypersecretion when taking Lisinopril *:
Common drugs people take besides Lisinopril *:
Common side effects people have besides Paranasal sinus hypersecretion *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lisinopril and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
Alternative drugs to, pros and cons of Lisinopril:
- Lisinopril (305,799 reports)
Paranasal sinus hypersecretion treatments and more:
- Paranasal sinus hypersecretion (3,854 reports)
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
How severe was Paranasal sinus hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of lisinopril:
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (655 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (375 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lisinopril (the active ingredients of Lisinopril) and Lisinopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vytorin and Inflammatory Carcinoma Of The Breast - 4 seconds ago
- Lovenox and Celebrex drug interaction - 13 seconds ago
- Minocycline Hydrochloride and Albuterol Sulfate drug interaction - 17 seconds ago
- Bactrim and Hyperhidrosis - 28 seconds ago
- Thyrogen and Salivary Gland Enlargement - 30 seconds ago